AZTA

Azenta Inc

• TipRanks·4d ago

  Azenta Reshapes Multiomics Leadership and Executive Compensation

• Reuters·4d ago

  Azenta names Trey Martin Multiomics president as Ginger Zhou steps down

• Dow Jones·4d ago

  Press Release: Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

• Dow Jones·5d ago

  Azenta Is Maintained at Outperform by Evercore ISI Group

• Benzinga·5d ago

  Evercore ISI Group Maintains Outperform on Azenta, Lowers Price Target to $35

• Simply Wall St·6d ago

  Assessing Azenta (AZTA) Valuation After Recent Share Price Rebound And Margin Expansion Hopes

• Dow Jones·04/02 22:50

  Stocks to Watch: PMGC, Azenta

• Dow Jones·04/02 20:55

  Azenta Weighs Options After Thelema Fails to Secure Acquisition Financing in Time

• TipRanks·04/02 20:38

  Azenta Faces Delay in B Medical Systems Divestiture

• Reuters·04/02 20:13

  AZENTA INC - AGREEMENT NOT AMENDED OR TERMINATED; COMPANY EVALUATING POTENTIAL PATHS FORWARD - SEC FILING

• Reuters·04/02 20:12

  Azenta says B Medical sale misses March 31 close as buyer financing delayed

• Benzinga·04/01 21:05

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• TipRanks·04/01 18:00

  Azenta price target lowered to $35 from $40 at Jefferies

• Seeking Alpha·03/24 22:38

  Azenta: Life Science Player Fails To Come To Life

• TipRanks·03/17 11:01

  Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Prime Medicine, Inc. (PRME) and Azenta (AZTA)